Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis

Nature Medicine volume 15, pages 1066–1071 (2009)Cite this article

Abstract

Bone metabolism results from a balance between osteoclast-driven bone resorption and osteoblast-mediated bone formation. Diseases such as periodontitis and rheumatoid arthritis are characterized by increased bone destruction due to enhanced osteoclastogenesis1,2. Here we report that interferon regulatory factor-8 (IRF-8), a transcription factor expressed in immune cells, is a key regulatory molecule for osteoclastogenesis. IRF-8 expression in osteoclast precursors was downregulated during the initial phase of osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand (RANKL), which is encoded by the Tnfsf11 gene. Mice deficient in Irf8 showed severe osteoporosis, owing to increased numbers of osteoclasts, and also showed enhanced bone destruction after lipopolysaccharide (LPS) administration. Irf8−/− osteoclast precursors underwent increased osteoclastogenesis in response to RANKL and tumor necrosis factor-α (TNF-α). IRF-8 suppressed osteoclastogenesis by inhibiting the function and expression of nuclear factor of activated T cells c1 (NFATc1). Our results show that IRF-8 inhibits osteoclast formation under physiological and pathological conditions and suggest a model where downregulation of inhibitory factors such as IRF-8 contributes to RANKL-mediated osteoclastogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IRF-8 inhibits osteoclastogenesis in BMMs stimulated with M-CSF and RANKL.
Figure 2: Irf8−/− mice show severe osteoporosis due to enhanced osteoclast formation.
Figure 3: IRF-8 deficiency or RNA interference–mediated silencing in osteoclast precursors leads to enhanced osteoclast formation.
Figure 4: IRF-8 inhibits NFATc1 transcriptional activity and expression, and reduced IRF-8 expression may contribute to pathological bone destruction.

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17–25 (2006).

    Article  CAS  Google Scholar 

  2. Lee, S.K. & Lorenzo, J. Cytokines regulating osteoclast formation and function. Curr. Opin. Rheumatol. 18, 411–418 (2006).

    Article  CAS  Google Scholar 

  3. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889–901 (2002).

    Article  CAS  Google Scholar 

  4. Grigoriadis, A.E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443–448 (1994).

    Article  CAS  Google Scholar 

  5. Kim, N., Takami, M., Rho, J., Josien, R. & Choi, Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195, 201–209 (2002).

    Article  CAS  Google Scholar 

  6. Ishida, N. et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277, 41147–41156 (2002).

    Article  CAS  Google Scholar 

  7. Kantakamalakul, W. et al. Regulation of IFN consensus sequence binding protein expression in murine macrophages. J. Immunol. 162, 7417–7425 (1999).

    CAS  PubMed  Google Scholar 

  8. Nelson, N. et al. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 156, 3711–3720 (1996).

    CAS  PubMed  Google Scholar 

  9. Driggers, P.H. et al. An interferon γ–regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 87, 3743–3747 (1990).

    Article  CAS  Google Scholar 

  10. Tamura, T. & Ozato, K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22, 145–152 (2002).

    Article  CAS  Google Scholar 

  11. Marecki, S. & Fenton, M.J. PU.1/interferon regulatory factor interactions: mechanisms of transcriptional regulation. Cell Biochem. Biophys. 33, 127–148 (2000).

    Article  CAS  Google Scholar 

  12. Holtschke, T. et al. Immunodeficiency and chronic myelogenous leukemia–like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307–317 (1996).

    Article  CAS  Google Scholar 

  13. Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T. & Ozato, K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13, 155–165 (2000).

    Article  CAS  Google Scholar 

  14. Schiavoni, G. et al. ICSBP is essential for the development of mouse type I interferon–producing cells and for the generation and activation of CD8α+ dendritic cells. J. Exp. Med. 196, 1415–1425 (2002).

    Article  CAS  Google Scholar 

  15. Zhu, C. et al. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J. Biol. Chem. 278, 39372–39382 (2003).

    Article  Google Scholar 

  16. Tsujimura, H. et al. Toll-like receptor 9 signaling activates NF-κB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172, 6820–6827 (2004).

    Article  CAS  Google Scholar 

  17. Zhao, J. et al. IRF-8/interferon (IFN) consensus sequence–binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-γ signaling pathways. J. Biol. Chem. 281, 10073–10080 (2006).

    Article  CAS  Google Scholar 

  18. Takami, M., Kim, N., Rho, J. & Choi, Y. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169, 1516–1523 (2002).

    Article  CAS  Google Scholar 

  19. O'Neill, L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3–9 (2006).

    Article  CAS  Google Scholar 

  20. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).

    Article  CAS  Google Scholar 

  21. Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243–249 (2005).

    Article  CAS  Google Scholar 

  22. Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. & Kudo, A. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275, 4858–4864 (2000).

    Article  CAS  Google Scholar 

  23. Kobayashi, K. et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191, 275–286 (2000).

    Article  CAS  Google Scholar 

  24. Kim, N. et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202, 589–595 (2005).

    Article  CAS  Google Scholar 

  25. Lorenzo, J., Horowitz, M. & Choi, Y. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29, 403–440 (2008).

    Article  CAS  Google Scholar 

  26. Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408, 600–605 (2000).

    Article  CAS  Google Scholar 

  27. Takayanagi, H. et al. RANKL maintains bone homeostasis through c-Fos–dependent induction of interferon-β. Nature 416, 744–749 (2002).

    Article  CAS  Google Scholar 

  28. Mochizuki, A. et al. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand. J. Immunol. 177, 4360–4368 (2006).

    Article  CAS  Google Scholar 

  29. Koga, T. et al. NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880–885 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to M. Asagiri for technical assistance. We thank T. Kitamura (University of Tokyo) for providing the retrovirus expression system. We also thank A. Mochizuki and all members of the Department of Biochemistry, School of Dentistry, Showa University for valuable discussions. This work is supported in part by the High-Tech Research Center Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology, Japan, 2005-2009, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (20390474 to M.T.) and by grants from the US National Institutes of Health (AR053843 and DE19381 to Y.C. and DE019420 and AR46713 to L.B.I.).

Author information

Authors and Affiliations

  1. Department of Biochemistry, School of Dentistry, Showa University, Shinagawa, Tokyo, Japan

    Baohong Zhao, Masamichi Takami, Atsushi Yamada, Xiaogu Wang & Ryutaro Kamijo

  2. Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York, USA

    Baohong Zhao, Xiaoyu Hu & Lionel B Ivashkiv

  3. Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

    Takako Koga & Hiroshi Takayanagi

  4. Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo, Japan

    Takako Koga & Hiroshi Takayanagi

  5. Department of Medicine, Weill Cornell Medical College, New York, New York, USA

    Xiaoyu Hu & Lionel B Ivashkiv

  6. Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

    Tomohiko Tamura & Keiko Ozato

  7. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Yongwon Choi

  8. Graduate Program in Immunology and Microbial Pathogenesis, Weill Graduate School of Medical Sciences of Cornell University, New York, New York, USA

    Lionel B Ivashkiv

Authors
  1. Baohong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masamichi Takami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsushi Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaogu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takako Koga
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoyu Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomohiko Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Keiko Ozato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yongwon Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Lionel B Ivashkiv
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroshi Takayanagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ryutaro Kamijo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

B.Z. performed most of the experiments with substantial assistance from M.T. X.W. conducted the histological analysis. A.Y., T.K., X.H. and T.T. assisted with the experiments. K.O. provided the Irf8−/− mice. B.Z. and M.T. designed the project and wrote the manuscript. Y.C. provided recombinant RANKL and contributed to manuscript preparation. L.B.I. oversaw the bone marrow chimera and human cell experiments and contributed to manuscript revision. H.T. oversaw the inflammatory bone destruction experiments and provided crucial advice for the experiments. M.T. and R.K. supervised the project.

Corresponding author

Correspondence to Masamichi Takami.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–7 and Supplementary Methods (PDF 343 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, B., Takami, M., Yamada, A. et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med 15, 1066–1071 (2009). https://doi.org/10.1038/nm.2007

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2007

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing